Genomic Health's diagnostic tests offer innovative cancer screening.


Updates from The Motley Fool

Latest updates on Genomic Health from Fool.com.  The Fool has written over 100 articles on Genomic Health.


Stock Performance

View Interactive GHDX Charts
Sponsored by

Key Data Points

Primary metrics and data points about Genomic Health.
Current Price: $70.13
Prev Close: $69.95
Open: $69.12
Bid: $70.26
Ask: $70.44
Day's Range: $68.32 - $71.31
52wk Range: $27.97 - $92.18
Volume: 114,026
Avg Vol 538,216
Market Cap: $2B
P/E (ttm): 137.16
EPS (ttm): $0.51
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Genomic Health.
CAPS Rating 4 out of 5
 
316 Outperform
19 Underperform
CAPS All Stars
 
91 Outperform
3 Underperform

How do you think Genomic Health will perform against the market?



You pick for Genomic Health is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Kim Popovits, CEO

68% Approve

Based on 76 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Genomic Health.

Genomic Health's diagnostic tests offer innovative cancer screening.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT